Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study

Authors: Fu-Gui Ye, Chen Xia, Ding Ma, Pei-Yang Lin, Xin Hu, Zhi-Ming Shao

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Invasive micropapillary carcinoma (IMPC) is an unusual and distinct subtype of invasive breast tumor with high propensity for regional lymph node metastases. This study was to identify risk factors accounting for IMPC of the breast and to develop a nomogram to preoperatively predict the probability of lymph node involvement.

Methods

A retrospective review of the clinical and pathology records was performed in patients diagnosed with IMPC between 2003 and 2014 from Surveillance, Epidemiology, and End Results (SEER) database. The cohort was divided into training and validation sets. Training set comprised patients diagnosed between 2003 and 2009, while validation set included patients diagnosed thereafter. A logistic regression model was used to construct the nomogram in the training set and then varified in the validation set. Nomogram performance was quantified with respect to discrimination and calibration using R 3.4.1 software.

Results

Overall, 1407 patients diagnosed with IMPC were enrolled, of which 527 in training set and 880 in validation set. Logistic regression analysis indicated larger lesions, younger age at diagnosis, black ethnic and lack of hormone receptor expression were significantly related to regional nodes involvement. The AUC of the nomogram was 0.735 (95% confidential interval (CI) 0.692 to 0.777), demonstrating a good prediction performance. Calibration curve for the nomogram was plotted and the slope was close to 1, which demonstrated excellent calibration of the nomogram. The performance of the nomogram was further validated in the validation set, with AUC of 0.748 (95% CI 0.701 to 0.767).

Conclusions

The striking difference between IMPC and IDC remains the increased lymph node involvement in IMPC and therefore merits aggressive treatment. The nomogram based on the clinicalpathologic parameters was established, which could accurately preoperatively predict regional lymph node status. This nomogram would facilitate evaluating lymph node state preoperatively and thus treatment decision-making of individual patients.
Literature
1.
go back to reference Fisher ER, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4): VI. Invasive papillary Cancer. Am J Clin Pathol. 1980;73(3):313–22.CrossRef Fisher ER, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4): VI. Invasive papillary Cancer. Am J Clin Pathol. 1980;73(3):313–22.CrossRef
2.
go back to reference Siriaunkgul S, Tavassoli F. Invasive micropapillary carcinoma of the breast. Mod Pathol. 1993;6(6):660–2.PubMed Siriaunkgul S, Tavassoli F. Invasive micropapillary carcinoma of the breast. Mod Pathol. 1993;6(6):660–2.PubMed
3.
go back to reference Tavassoli FA, Devilee P. Pathology and genetics of tumours of Breast and female genital organs: pathology and genetics. Verh Dtsch Ges Pathol. 2002;86:116–9. Tavassoli FA, Devilee P. Pathology and genetics of tumours of Breast and female genital organs: pathology and genetics. Verh Dtsch Ges Pathol. 2002;86:116–9.
4.
go back to reference Luna-More S, et al. Invasive micropapillary carcinoma of the breast*: a new special type of invasive mammary carcinoma. Pathology-Research and Practice. 1994;190(7):668–74.CrossRef Luna-More S, et al. Invasive micropapillary carcinoma of the breast*: a new special type of invasive mammary carcinoma. Pathology-Research and Practice. 1994;190(7):668–74.CrossRef
5.
go back to reference Luna-More S, et al. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathology-Research and Practice. 1996;192(1):27–32.CrossRef Luna-More S, et al. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathology-Research and Practice. 1996;192(1):27–32.CrossRef
6.
go back to reference Nassar H, et al. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14(9):836.CrossRef Nassar H, et al. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14(9):836.CrossRef
7.
go back to reference Paterakos M, et al. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol. 1999;30(12):1459–63.CrossRef Paterakos M, et al. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol. 1999;30(12):1459–63.CrossRef
8.
go back to reference Middleton L, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12(5):499–504.PubMed Middleton L, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12(5):499–504.PubMed
9.
go back to reference Guo X, et al. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Mod Pathol. 2008;21(9):1101.CrossRef Guo X, et al. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Mod Pathol. 2008;21(9):1101.CrossRef
10.
go back to reference Wei J, et al. E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Int J Surg Pathol. 2010;18(3):193–200.CrossRef Wei J, et al. E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Int J Surg Pathol. 2010;18(3):193–200.CrossRef
11.
go back to reference Liu F, et al. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology. 2009;54(6):741–50.CrossRef Liu F, et al. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Histopathology. 2009;54(6):741–50.CrossRef
12.
go back to reference Ren M, et al. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome. Virchows Arch. 2014;465(3):291–8.CrossRef Ren M, et al. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome. Virchows Arch. 2014;465(3):291–8.CrossRef
13.
go back to reference Li S, et al. Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast. Breast Cancer Res Treat. 2012;136(1):77–87.CrossRef Li S, et al. Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast. Breast Cancer Res Treat. 2012;136(1):77–87.CrossRef
14.
go back to reference Wang X-X, et al. Loss of leucine zipper putative tumor suppressor 1 (LZTS1) expression contributes to lymph node metastasis of breast invasive micropapillary carcinoma. Pathology & Oncology Research. 2015;21(4):1021–6.CrossRef Wang X-X, et al. Loss of leucine zipper putative tumor suppressor 1 (LZTS1) expression contributes to lymph node metastasis of breast invasive micropapillary carcinoma. Pathology & Oncology Research. 2015;21(4):1021–6.CrossRef
15.
go back to reference Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–6.CrossRef Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–6.CrossRef
16.
go back to reference Rasponi A, et al. Breast cancer: primary tumor characteristics related to lymph node involvement. Tumori. 1981;67(1):19–26.CrossRef Rasponi A, et al. Breast cancer: primary tumor characteristics related to lymph node involvement. Tumori. 1981;67(1):19–26.CrossRef
17.
go back to reference Mohammed H, et al. Progesterone receptor modulates ERalpha action in breast cancer. Nature. 2015;523(7560):313–7.CrossRef Mohammed H, et al. Progesterone receptor modulates ERalpha action in breast cancer. Nature. 2015;523(7560):313–7.CrossRef
18.
go back to reference Page DL. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol. 1991;15(4):334–49.CrossRef Page DL. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am J Surg Pathol. 1991;15(4):334–49.CrossRef
19.
go back to reference Li YS, et al. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer. 2006;13(1):58–63.CrossRef Li YS, et al. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast. Breast Cancer. 2006;13(1):58–63.CrossRef
20.
go back to reference Pettinato G, et al. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol. 2004;121(6):857–66.CrossRef Pettinato G, et al. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol. 2004;121(6):857–66.CrossRef
21.
go back to reference Tresserra F, et al. Invasive micropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol. 1999;20(3):205–8.PubMed Tresserra F, et al. Invasive micropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol. 1999;20(3):205–8.PubMed
22.
go back to reference Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32(6):583–9.CrossRef Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32(6):583–9.CrossRef
23.
go back to reference Guo X, et al. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Am J Clin Pathol. 2006;126(5):740–6.CrossRef Guo X, et al. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Am J Clin Pathol. 2006;126(5):740–6.CrossRef
24.
go back to reference Zekioglu O, et al. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 2004;44(1):18–23.CrossRef Zekioglu O, et al. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 2004;44(1):18–23.CrossRef
25.
go back to reference Adrada B, et al. Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features. AJR Am J Roentgenol. 2009;193(1):W58–63.CrossRef Adrada B, et al. Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features. AJR Am J Roentgenol. 2009;193(1):W58–63.CrossRef
26.
go back to reference Chen L, et al. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16(2):155–63.CrossRef Chen L, et al. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16(2):155–63.CrossRef
27.
go back to reference Yu JI, et al. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case–control study. Breast. 2010;19(3):231–7.CrossRef Yu JI, et al. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case–control study. Breast. 2010;19(3):231–7.CrossRef
28.
go back to reference Liu Y, et al. Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China. PLoS One. 2014;9(9):e106564.CrossRef Liu Y, et al. Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China. PLoS One. 2014;9(9):e106564.CrossRef
29.
go back to reference Yoshihara E, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast. 2013;22(3):357–61.CrossRef Yoshihara E, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast. 2013;22(3):357–61.CrossRef
30.
go back to reference Sandoughdaran S, Malekzadeh M, Akbari ME. Frequency and predictors of axillary lymph node metastases in Iranian women with early breast Cancer. Asian Pac J Cancer Prev. 2018;19(6):1617.PubMedPubMedCentral Sandoughdaran S, Malekzadeh M, Akbari ME. Frequency and predictors of axillary lymph node metastases in Iranian women with early breast Cancer. Asian Pac J Cancer Prev. 2018;19(6):1617.PubMedPubMedCentral
31.
go back to reference Si C, et al. Association between molecular subtypes and lymph node status in invasive breast cancer. Int J Clin Exp Pathol. 2014;7(10):6800.PubMedPubMedCentral Si C, et al. Association between molecular subtypes and lymph node status in invasive breast cancer. Int J Clin Exp Pathol. 2014;7(10):6800.PubMedPubMedCentral
32.
go back to reference Katz A, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node–positive breast cancer. J Clin Oncol. 2008;26(13):2093–8.CrossRef Katz A, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node–positive breast cancer. J Clin Oncol. 2008;26(13):2093–8.CrossRef
33.
go back to reference Tang SL, et al. Clinicopathologic study of invasive micropapillary carcinoma of the breast. Oncotarget. 2017;8(26):42455–65.CrossRef Tang SL, et al. Clinicopathologic study of invasive micropapillary carcinoma of the breast. Oncotarget. 2017;8(26):42455–65.CrossRef
Metadata
Title
Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study
Authors
Fu-Gui Ye
Chen Xia
Ding Ma
Pei-Yang Lin
Xin Hu
Zhi-Ming Shao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4982-5

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine